Literature DB >> 27878645

The Synaptojanins in the murine small and large intestine.

María Dolores Vázquez-Carretero1, Ana Eloisa Carvajal1, José Manuel Serrano-Morales1, Pablo García-Miranda1, Anunciación Ana Ilundain1, María José Peral2.   

Abstract

The expression of the phosphoinositides phosphatases Synaptojanins (Synjs) 1 and 2 has been shown in brain and in some peripheral tissues, but their expression in the intestine has not been reported. Herein we show that the small and large intestine express Synj1 and Synj2. Their mRNA levels, measured by RT-PCR, are not affected by development in the small intestine but in the colon they increase with age. Immunostaining assays reveal that both Synjs localize at the apical domain of the epithelial cells and at the lamina propria at sites also expressing the neuron marker calretinin. Synj2 staining at the lamina propria is fainter than that of Synj1. In colonocytes Synjs are at the apical membrane and cytosolic membrane vesicles. Synj2 is also at the mitochondria. Western blots reveal that the intestinal mucosa expresses at least two Synj1 (170- and 139-kDa) and two Synj2 (160- and 148-kDa) isoforms. The observations suggest that Synj1-170, Synj2-160, and Synj2-148 in colonocytes, might participate in processes that take place mainly at the apical domain of the epithelial cells whereas Synj1-139 in those at the enteric nervous system. Experimental colitis augments the mRNA abundance of both Synjs in colon but only Synj2 mRNA levels are increased in colon tumors. In conclusion, as far as we know, this is the first report showing expression, location and isoforms of Synj1 and Synj2 in the small and large intestine and that they might participate in intestinal pathology.

Entities:  

Keywords:  Colon; Intestine; Synaptojanin1; Synaptojanin2

Mesh:

Substances:

Year:  2016        PMID: 27878645     DOI: 10.1007/s10863-016-9689-1

Source DB:  PubMed          Journal:  J Bioenerg Biomembr        ISSN: 0145-479X            Impact factor:   2.945


  35 in total

1.  Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method.

Authors:  K J Livak; T D Schmittgen
Journal:  Methods       Date:  2001-12       Impact factor: 3.608

2.  Promotion of colorectal neoplasia in experimental murine ulcerative colitis.

Authors:  I Okayasu; T Ohkusa; K Kajiura; J Kanno; S Sakamoto
Journal:  Gut       Date:  1996-07       Impact factor: 23.059

3.  Developmentally regulated alternative splicing in a novel synaptojanin.

Authors:  M Khvotchev; T C Südhof
Journal:  J Biol Chem       Date:  1998-01-23       Impact factor: 5.157

4.  Synaptojanin 2 is a druggable mediator of metastasis and the gene is overexpressed and amplified in breast cancer.

Authors:  Nir Ben-Chetrit; David Chetrit; Roslin Russell; Cindy Körner; Maicol Mancini; Ali Abdul-Hai; Tomer Itkin; Silvia Carvalho; Hadas Cohen-Dvashi; Wolfgang J Koestler; Kirti Shukla; Moshit Lindzen; Merav Kedmi; Mattia Lauriola; Ziv Shulman; Haim Barr; Dalia Seger; Daniela A Ferraro; Fresia Pareja; Hava Gil-Henn; Tsvee Lapidot; Ronen Alon; Fernanda Milanezi; Marc Symons; Rotem Ben-Hamo; Sol Efroni; Fernando Schmitt; Stefan Wiemann; Carlos Caldas; Marcelo Ehrlich; Yosef Yarden
Journal:  Sci Signal       Date:  2015-01-20       Impact factor: 8.192

5.  Analysis of an intronic promoter within Synj2.

Authors:  Antonio Planchart
Journal:  Biochem Biophys Res Commun       Date:  2013-10-05       Impact factor: 3.575

6.  A presynaptic inositol-5-phosphatase.

Authors:  P S McPherson; E P Garcia; V I Slepnev; C David; X Zhang; D Grabs; W S Sossin; R Bauerfeind; Y Nemoto; P De Camilli
Journal:  Nature       Date:  1996-01-25       Impact factor: 49.962

7.  Molecular cloning of multiple isoforms of synaptojanin 2 and assignment of the gene to mouse chromosome 17A2-3.1.

Authors:  L F Seet; S Cho; A Hessel; D J Dumont
Journal:  Biochem Biophys Res Commun       Date:  1998-06-09       Impact factor: 3.575

8.  Role of dynamin, synaptojanin, and endophilin in podocyte foot processes.

Authors:  Keita Soda; Daniel M Balkin; Shawn M Ferguson; Summer Paradise; Ira Milosevic; Silvia Giovedi; Laura Volpicelli-Daley; Xuefei Tian; Yumei Wu; Hong Ma; Sung Hyun Son; Rena Zheng; Gilbert Moeckel; Ottavio Cremona; Lawrence B Holzman; Pietro De Camilli; Shuta Ishibe
Journal:  J Clin Invest       Date:  2012-11-26       Impact factor: 14.808

9.  A mutation in synaptojanin 2 causes progressive hearing loss in the ENU-mutagenised mouse strain Mozart.

Authors:  Shehnaaz S M Manji; Louise H Williams; Kerry A Miller; Lisa M Ooms; Melanie Bahlo; Christina A Mitchell; Hans-Henrik M Dahl
Journal:  PLoS One       Date:  2011-03-15       Impact factor: 3.240

10.  Regulation of synaptojanin 2 5'-phosphatase activity by Src.

Authors:  Yayu Chuang; Xiaonan Xu; Aneta Kwiatkowska; George Tsapraillis; Hyonson Hwang; Konstantinos Petritis; Dan Flynn; Marc Symons
Journal:  Cell Adh Migr       Date:  2012-10-17       Impact factor: 3.405

View more
  1 in total

1.  Identifying the Prognostic Risk Factors of Synaptojanin 2 and Its Underlying Perturbations Pathways in Hepatocellular Carcinoma.

Authors:  Rui Zhang; Wei-Jia Mo; Lan-Shan Huang; Ji-Tian Chen; Wei-Zi Wu; Wei-Ying He; Zhen-Bo Feng
Journal:  Bioengineered       Date:  2021-12       Impact factor: 3.269

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.